Industry Growth Insights published a new data on “Drug Delivery in Cancer Market”. The research report is titled “Drug Delivery in Cancer Market research by Types (Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein-drug Conjugates, Others), By Applications (Hospitals & Clinic, Cancer Treatment Centers, Others), By Players/Companies Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences, Pfizer, Dr Reddy, Samyang Biopharmaceuticals, Tolmar, Astellas, AMAG Pharmaceuticals, AstraZeneca, AbbVie, Novartis, Aspen, Shire (Baxalta), Breckenridge Pharmaceuticals, Galen Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Delivery in Cancer Market Research Report
By Type
Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein-drug Conjugates, Others
By Application
Hospitals & Clinic, Cancer Treatment Centers, Others
By Companies
Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences, Pfizer, Dr Reddy, Samyang Biopharmaceuticals, Tolmar, Astellas, AMAG Pharmaceuticals, AstraZeneca, AbbVie, Novartis, Aspen, Shire (Baxalta), Breckenridge Pharmaceuticals, Galen Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Drug Delivery in Cancer Market Report Segments:
The global Drug Delivery in Cancer market is segmented on the basis of:
Types
Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein-drug Conjugates, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinic, Cancer Treatment Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Teva
- UCB (Union Chimique Belge)
- Roche
- Celgene
- Sanofi
- Merck
- Johnson & Johnson
- Takeda
- Gilead Sciences
- Pfizer
- Dr Reddy
- Samyang Biopharmaceuticals
- Tolmar
- Astellas
- AMAG Pharmaceuticals
- AstraZeneca
- AbbVie
- Novartis
- Aspen
- Shire (Baxalta)
- Breckenridge Pharmaceuticals
- Galen Pharmaceuticals
Highlights of The Drug Delivery in Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein-drug Conjugates
- Others
- By Application:
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Delivery in Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug delivery in cancer is the process of getting drugs to where they are needed most in the body. Drugs can be delivered directly to tumors or through the bloodstream and lymphatic system.
Some of the major companies in the drug delivery in cancer market are Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences, Pfizer, Dr Reddy, Samyang Biopharmaceuticals, Tolmar, Astellas, AMAG Pharmaceuticals, AstraZeneca, AbbVie, Novartis, Aspen, Shire (Baxalta), Breckenridge Pharmaceuticals, Galen Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Delivery in Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Delivery in Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Delivery in Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Delivery in Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Delivery in Cancer Market Size & Forecast, 2018-2028
4.5.1 Drug Delivery in Cancer Market Size and Y-o-Y Growth
4.5.2 Drug Delivery in Cancer Market Absolute $ Opportunity
Chapter 5 Global Drug Delivery in Cancer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Delivery in Cancer Market Size Forecast by Type
5.2.1 Liposomes
5.2.2 PEGylated Proteins & Polypeptides
5.2.3 Polymer Nanoparticle
5.2.4 Protein-drug Conjugates
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Delivery in Cancer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Delivery in Cancer Market Size Forecast by Applications
6.2.1 Hospitals & Clinic
6.2.2 Cancer Treatment Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Delivery in Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Delivery in Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Delivery in Cancer Analysis and Forecast
9.1 Introduction
9.2 North America Drug Delivery in Cancer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Delivery in Cancer Market Size Forecast by Type
9.6.1 Liposomes
9.6.2 PEGylated Proteins & Polypeptides
9.6.3 Polymer Nanoparticle
9.6.4 Protein-drug Conjugates
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Delivery in Cancer Market Size Forecast by Applications
9.10.1 Hospitals & Clinic
9.10.2 Cancer Treatment Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Delivery in Cancer Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Delivery in Cancer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Delivery in Cancer Market Size Forecast by Type
10.6.1 Liposomes
10.6.2 PEGylated Proteins & Polypeptides
10.6.3 Polymer Nanoparticle
10.6.4 Protein-drug Conjugates
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Delivery in Cancer Market Size Forecast by Applications
10.10.1 Hospitals & Clinic
10.10.2 Cancer Treatment Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Delivery in Cancer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Delivery in Cancer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Delivery in Cancer Market Size Forecast by Type
11.6.1 Liposomes
11.6.2 PEGylated Proteins & Polypeptides
11.6.3 Polymer Nanoparticle
11.6.4 Protein-drug Conjugates
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Delivery in Cancer Market Size Forecast by Applications
11.10.1 Hospitals & Clinic
11.10.2 Cancer Treatment Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Delivery in Cancer Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Delivery in Cancer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Delivery in Cancer Market Size Forecast by Type
12.6.1 Liposomes
12.6.2 PEGylated Proteins & Polypeptides
12.6.3 Polymer Nanoparticle
12.6.4 Protein-drug Conjugates
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Delivery in Cancer Market Size Forecast by Applications
12.10.1 Hospitals & Clinic
12.10.2 Cancer Treatment Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Delivery in Cancer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Delivery in Cancer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Delivery in Cancer Market Size Forecast by Type
13.6.1 Liposomes
13.6.2 PEGylated Proteins & Polypeptides
13.6.3 Polymer Nanoparticle
13.6.4 Protein-drug Conjugates
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Delivery in Cancer Market Size Forecast by Applications
13.10.1 Hospitals & Clinic
13.10.2 Cancer Treatment Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Delivery in Cancer Market: Competitive Dashboard
14.2 Global Drug Delivery in Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
14.3.1 Amgen
14.3.2 Teva
14.3.3 UCB (Union Chimique Belge)
14.3.4 Roche
14.3.5 Celgene
14.3.6 Sanofi
14.3.7 Merck
14.3.8 Johnson & Johnson
14.3.9 Takeda
14.3.10 Gilead Sciences
14.3.11 Pfizer
14.3.12 Dr Reddy
14.3.13 Samyang Biopharmaceuticals
14.3.14 Tolmar
14.3.15 Astellas
14.3.16 AMAG Pharmaceuticals
14.3.17 AstraZeneca
14.3.18 AbbVie
14.3.19 Novartis
14.3.20 Aspen
14.3.21 Shire (Baxalta)
14.3.22 Breckenridge Pharmaceuticals
14.3.23 Galen Pharmaceuticals
